Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-carnitine in peritoneal dialysis patients
IRCT138806022370N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levocarnitine in end-stage kidney disease (ESKD), sponsored by Isfahan University of Medical Sciences. Started Aug 2008; status: completed.
02
Drugs
levocarnitine
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on IRCT138806022370N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138806022370N1.